Published in Immunotherapy Weekly, January 30th, 2008
"However, contrary to the lambda superinfection immunity model, it has been demonstrated that double lysogens can be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2008-01-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.